Skip to main content

Table 1 Patients profiles

From: A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

Patient no.

Age

Contents (p.f.u) X Time

Injection site

Staginga (radiological)

Staginga (postoperative)

Cohort 1

HF-1-02

60s

1X106X4

Pancreas head

III (T4N0M0)

NA

HF-1-04

60s

1X106X4

Pancreas head (uncinate process)

III (T4N0M0)

NA

HF-1-05

60s

1X106X4

Pancreas body

III (T4N0M0)

IIA (T3N0M0)

Cohort 2

HF-2-01

60s

3X106X4

Pancreas body

III (T4N0M0)

NA

HF-2-02

60s

3X106X4

Pancreas head (uncinate process)

III (T4N0M0)

IIA (T3N0M0)

HF-2-03

60s

3X106X4

Pancreas body

III (T4N0M0)

NA

Cohort 3

HF-3-01

60s

1X107X3

Pancreas body

III (T4N0M0)

NA

HF-3-02

50s

1X107X4

Pancreas head (uncinate process)

III (T4N0M0)

NA

HF-3-03

60s

1X107X4

Pancreas body

III (T4N0M0)

NA

HF-3-04

60s

1X107X4

Pancreas head

III (T4N0M0)

NA

  1. aBased on NCCN Clinical Practice Guidelines in Oncology [13]